Systemic sclerosis: can we identify patients at risk?

Leeuwen, N.M. van (2022)

Doctoral Thesis

The studies described in this thesis contribute to the identification of biomarkers for risk stratification in systemic sclerosis (SSc). Luckily, nowadays many SSc prospective cohorts have been set up worldwide which allows high-quality research. Given the rarity and the heterogeneity of the disease, relatively large cohorts are needed to draw valuable conclusions. For the studies described in the current thesis, I was able to incorporate data from the Leiden prospective SSc cohort and data from other prospective cohorts in Europe, which made it possible to strengthen the data. In this final chapter, I summarize the main findings of the studies presented in this thesis, put our findings in a broader perspective, discuss future perspectives and formulate research questions that are relevant to assess in the years ahead of us.

• Systemic Sclerosis
• Risk factors
• Biomarkers

• All authors: Leeuwen, N.M. van
• Supervisor: Huizinga, T.W.J.
• Co-supervisor: Vries-Bouwstra, J.K. de
• Committee: Toes, R.E.M,; Hoffmann-Vold, A.M.; Laar, J.M. van; Vonk, M.C.
• Qualification: Doctor (dr.)
• Awarding Institution: Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University
• Date: 2022-03-17
• ISBN (print): 9789464161014
• Sponsorship: ChipSoft; UCB Pharma; NVLE fonds; Boehringer Ingelheim